Treatment-resistant depression or TRD is exactly what it sounds like: a form of mental illness that defies effective therapy. It is not rare, with an
Read more
Home »
A combination therapy pairing a small molecule inhibitor with monoclonal antibody immunotherapy improved patient outcomes for relapsed chronic lymphocytic leukemia (CLL), according to a Northwestern
Read more
Over the past two decades, targeted cancer therapies have changed the prognosis for thousands of patients. By targeting the specific genetic mutation behind a patient’s
Read more
(HealthDay)—Plenty of teens are burdened with a chronic and often paralyzing fear of being harshly judged by others. Unfortunately, many can’t get in-person treatment that
Read more
Research led by scientists at Children’s Cancer Institute and published this week in the international journal, Clinical Cancer Research, has found a combination of therapies
Read more
A new study by researchers at the VA Portland Health Care System in Oregon found that augmenting traditional treatment for traumatic brain injury (TBI) with
Read more
A new clinical trial from King’s College London’s Institute of Psychiatry, Psychology, & Neuroscience, in collaboration with Oxford University, Oxford Health NHS Foundation Trust, Sussex
Read more
Researchers have used a genetic engineering strategy to dramatically reduce levels of tau—a key protein that accumulates and becomes tangled in the brain during the
Read more
Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor’s response to targeted therapy, allowing physicians to select the most effective treatment for
Read more
A clinical trial of a new gene therapy for sickle cell disease that has shown promise has been halted after two participants were diagnosed with
Read more